Transfusion Medicine and Immunohematology

Blood transfusion is essential and vital in the successful treatment of many malignant and nonmalignant hematological disorders. Children with thalassemia, adults with myelodysplastic syndromes, and patients with autoimmune hemolytic anemias, leukemias, or aplastic anemias become chronically depende...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenorio, Grace C., Gupte, Snehalata C., Munker, Reinhold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155745/
http://dx.doi.org/10.1007/978-1-59745-149-9_22
_version_ 1783522101173420032
author Tenorio, Grace C.
Gupte, Snehalata C.
Munker, Reinhold
author_facet Tenorio, Grace C.
Gupte, Snehalata C.
Munker, Reinhold
author_sort Tenorio, Grace C.
collection PubMed
description Blood transfusion is essential and vital in the successful treatment of many malignant and nonmalignant hematological disorders. Children with thalassemia, adults with myelodysplastic syndromes, and patients with autoimmune hemolytic anemias, leukemias, or aplastic anemias become chronically dependent on blood transfusions. Modern treatment procedures such as high-dose chemotherapy and progenitor cell transplantation require intensive support with blood components and products. The serological basis of blood transfusion, the available blood components and products, and adverse effects of blood transfusion with special emphasis on infectious disease transmission are discussed in this chapter.
format Online
Article
Text
id pubmed-7155745
institution National Center for Biotechnology Information
language English
publishDate 2007
record_format MEDLINE/PubMed
spelling pubmed-71557452020-04-15 Transfusion Medicine and Immunohematology Tenorio, Grace C. Gupte, Snehalata C. Munker, Reinhold Modern Hematology Article Blood transfusion is essential and vital in the successful treatment of many malignant and nonmalignant hematological disorders. Children with thalassemia, adults with myelodysplastic syndromes, and patients with autoimmune hemolytic anemias, leukemias, or aplastic anemias become chronically dependent on blood transfusions. Modern treatment procedures such as high-dose chemotherapy and progenitor cell transplantation require intensive support with blood components and products. The serological basis of blood transfusion, the available blood components and products, and adverse effects of blood transfusion with special emphasis on infectious disease transmission are discussed in this chapter. 2007 /pmc/articles/PMC7155745/ http://dx.doi.org/10.1007/978-1-59745-149-9_22 Text en © Humana Press Inc., Totowa, NJ 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Tenorio, Grace C.
Gupte, Snehalata C.
Munker, Reinhold
Transfusion Medicine and Immunohematology
title Transfusion Medicine and Immunohematology
title_full Transfusion Medicine and Immunohematology
title_fullStr Transfusion Medicine and Immunohematology
title_full_unstemmed Transfusion Medicine and Immunohematology
title_short Transfusion Medicine and Immunohematology
title_sort transfusion medicine and immunohematology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155745/
http://dx.doi.org/10.1007/978-1-59745-149-9_22
work_keys_str_mv AT tenoriogracec transfusionmedicineandimmunohematology
AT guptesnehalatac transfusionmedicineandimmunohematology
AT munkerreinhold transfusionmedicineandimmunohematology

Ejemplares similares